{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/otitis-externa/prescribing-information/topical-ear-preparations/","result":{"pageContext":{"chapter":{"id":"e43fc276-0f45-52d9-97a9-394af935add3","slug":"topical-ear-preparations","fullItemName":"Topical ear preparations","depth":2,"htmlHeader":"<!-- begin field ce3d8554-0a92-41e5-a74f-35cf013348f4 --><h2>Topical ear preparations</h2><!-- end field ce3d8554-0a92-41e5-a74f-35cf013348f4 -->","summary":"","htmlStringContent":"<!-- begin item 2d0a98b3-4a1c-47ff-852a-6e1cef656b95 --><!-- end item 2d0a98b3-4a1c-47ff-852a-6e1cef656b95 -->","topic":{"id":"f876df90-ac8c-5343-ac27-cf0dce71d872","topicId":"0999db7d-67e0-4462-a7d7-c1cd5f57cf6a","topicName":"Otitis externa","slug":"otitis-externa","lastRevised":"Last revised in February 2018","chapters":[{"id":"66707be8-e82b-56aa-a7d4-2e83fd4e34f9","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc9f278a-f789-50fb-a43c-1b9fde28ef7f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"042a16b9-3050-5ecb-9199-e9f18527c183","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"736969ef-5779-5f8d-b3c8-95bc2137ea11","slug":"changes","fullItemName":"Changes"},{"id":"d74a591d-a4fa-5fa7-9a79-11341d8ad57c","slug":"update","fullItemName":"Update"}]},{"id":"922f046d-5114-504a-b7dd-1754b6b9de95","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"07126be4-c022-5eca-b29c-7b3bf9638295","slug":"goals","fullItemName":"Goals"},{"id":"fa385cc8-0093-54cd-ab27-8bf1de604bd7","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"5717d539-e1a2-5f48-9c65-a6e1c3523910","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d8e4c4a2-74ce-589f-856b-dfd3f0c0e8d9","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"b72bcdb9-0860-5e4e-ac10-b0ddef3274ed","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"dc6ecfda-2678-5466-b11f-c04e4a210a6c","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"c4e7ed77-cefa-531a-a475-7af487f17915","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"b6eaf075-9623-547f-88d8-987fc90c5bdf","slug":"definition","fullItemName":"Definition"},{"id":"c8342f48-2446-51c8-b164-710650b2b937","slug":"causes","fullItemName":"Causes"},{"id":"dfaffdb8-3a14-5de7-ae1f-aab5dd341ee9","slug":"complications","fullItemName":"Complications"},{"id":"a5cb2def-cfd9-5728-95fa-4e9bbceb7fd8","slug":"prognosis","fullItemName":"Prognosis"},{"id":"63c036e7-6c79-5164-bded-0583fa30260b","slug":"prevalence","fullItemName":"Prevalence"}]},{"id":"8aa1bc32-b762-5d5a-bfe3-378af9c545f3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c7df346e-5420-50ae-98ff-4e00234699d9","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"f3f8f6dd-87d1-5688-8f98-84eb3ec59ca5","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"1851ae55-865c-5488-902c-54822a2a76dd","fullItemName":"Management","slug":"management","subChapters":[{"id":"9f7ce67c-9805-5fef-a1f9-cc88a9085674","slug":"localized-otitis-externa","fullItemName":"Scenario: Localized otitis externa"},{"id":"d753f65b-ae51-5d11-8b85-4d833a89a428","slug":"acute-diffuse-otitis-externa","fullItemName":"Scenario: Acute diffuse otitis externa"},{"id":"7f39d3cc-526b-51bc-b091-6399e805f3cb","slug":"chronic-diffuse-otitis-externa","fullItemName":"Scenario: Chronic diffuse otitis externa"}]},{"id":"aa30911a-20a0-5191-ba4e-f48610d404b2","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e43fc276-0f45-52d9-97a9-394af935add3","slug":"topical-ear-preparations","fullItemName":"Topical ear preparations"},{"id":"b49a03f2-59c1-56ed-b894-9e01ce84d1a8","slug":"oral-analgesics","fullItemName":"Oral analgesics"},{"id":"fd97664d-7f15-5f36-a10c-7bcad2d057f2","slug":"oral-flucloxacillin","fullItemName":"Oral flucloxacillin"},{"id":"b186879f-d6d6-5afa-84d8-845ba42605c1","slug":"oral-clarithromycin","fullItemName":"Oral clarithromycin"}]},{"id":"8c363337-fc91-521b-a609-58b9b0ba4d8b","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9feebcb7-db7f-5a9f-a9a7-89f401ebca13","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8fc4ebd8-033e-5184-bb1e-cc1bd7de86e2","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"7580e3ff-a6f6-5f7b-9254-6772074d8d7b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"5162da22-b23f-5934-87a8-4aa96029fcde","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"babd7947-def4-5d00-a46e-c68902688a88","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"18fd5166-b294-56f8-8cf1-c2e4e2bfa31d","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"ae1ef912-929f-5085-9b08-d75ce3e016b7","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"aa30911a-20a0-5191-ba4e-f48610d404b2","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"09ac378c-e5fa-5fdb-94ae-3d6ba1d45681","slug":"available-preparations","fullItemName":"Available preparations","depth":3,"htmlHeader":"<!-- begin field d0d94833-e7d2-4aaa-a439-8627e7ac8855 --><h3>What topical ear preparations are available?</h3><!-- end field d0d94833-e7d2-4aaa-a439-8627e7ac8855 -->","summary":"","htmlStringContent":"<!-- begin item 44ba65c6-89c5-4e16-ae66-35f98a258665 --><!-- begin field 8ed6b09a-ec47-4c62-8fdf-755d2d23f3e5 --><p><strong>Table 1</strong>. Topical ear preparations available in the UK for treating otitis externa.</p><table><thead><tr><th><p><strong>Group</strong></p></th><th><p><strong>Products</strong></p></th></tr></thead><tbody><tr><td colspan=\"2\"><strong>Astringent/acidic preparations</strong></td></tr><tr><td>Astringent/Acidic</td><td><p>Aluminium acetate 8%* and 13% drops*</p><p>Acetic acid 2% spray (Earcalm®) †</p></td></tr><tr><td colspan=\"2\"><strong>Corticosteroid preparations</strong></td></tr><tr><td>Corticosteroid: lower potency</td><td>Prednisolone sodium phosphate 0.5% drops (Predsol®)</td></tr><tr><td>Corticosteroid: higher potency</td><td>Betamethasone sodium phosphate 0.1% drops (Betnesol®, Vista-methasone®)</td></tr><tr><td colspan=\"2\"><strong>Antibiotic preparations</strong></td></tr><tr><td>Aminoglycoside</td><td>Gentamicin 0.3% drops (Genticin®)</td></tr><tr><td>Non-aminoglycoside</td><td>Chloramphenicol 5% drops</td></tr><tr><td colspan=\"2\"><strong>Antifungal preparations</strong></td></tr><tr><td>Antifungal</td><td>Clotrimazole 1% solution (Canesten®)</td></tr><tr><td colspan=\"2\"><strong>Combined corticosteroid and antibiotic preparations</strong></td></tr><tr><td>Quinolone with corticosteroid</td><td> </td></tr><tr><td>Ciprofloxacin</td><td>Dexamethasone 0.1%, ciprofloxacin 0.3% (Cilodex®)</td></tr><tr><td colspan=\"2\"><strong>Aminoglycoside with corticosteroid</strong></td></tr><tr><td>Neomycin</td><td><p>Betamethasone sodium phosphate 0.1%, Neomycin sulphate 0.5% (drops: Betnesol-N®, Vista-Methasone N®)</p><p>Hydrocortisone 1%, neomycin sulphate 3400 units, polymyxin B sulphate 10,000 units/mL (drops: Otosporin®)</p><p>Prednisolone sodium phosphate 0.5%, neomycin sulphate 0.5% (drops: Predsol-N®)</p><p>Dexamethasone 0.1%, neomycin sulphate 3250 units/mL, glacial acetic acid 2% (spray: Otomize®)</p></td></tr><tr><td>Gentamicin</td><td>Hydrocortisone acetate 1%, gentamicin 0.3% (drops: Gentisone HC®)</td></tr><tr><td>Framycetin</td><td>Dexamethasone 0.05%, framycetin sulphate 0.5%, gramicidin 0.005% (drops: Sofradex®)</td></tr><tr><td colspan=\"2\"><strong>Combined corticosteroid and antibiotic/antifungal preparations</strong></td></tr><tr><td>Clioquinol with corticosteroid</td><td>Flumetasone pivalate 0.02%, clioquinol 1% </td></tr><tr><td colspan=\"2\">* Aluminium acetate 13% is available from manufacturers of 'special order' products. Aluminium acetate 8% can be made by diluting 8 parts aluminium acetate ear drops (13%) with 5 parts purified water (must be freshly prepared before use). † Available to buy over the counter. </td></tr><tr><td colspan=\"2\"><strong>Information from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">BNF 72, 2016</a>]</td></tr></tbody></table><!-- end field 8ed6b09a-ec47-4c62-8fdf-755d2d23f3e5 --><!-- end item 44ba65c6-89c5-4e16-ae66-35f98a258665 -->","subChapters":[]},{"id":"b102e36a-3931-522f-8a89-c2a38fbab86b","slug":"how-to-administer-ear-drops","fullItemName":"How to administer ear drops","depth":3,"htmlHeader":"<!-- begin field fb885aee-5573-4e89-824e-a293c6d6d040 --><h3>What advice should I give about administering ear drops?</h3><!-- end field fb885aee-5573-4e89-824e-a293c6d6d040 -->","summary":"","htmlStringContent":"<!-- begin item c1c3d488-24f8-4576-9fa5-2e6f123c81cc --><!-- begin field 800f79f3-6364-4867-92ba-3a4c9648691f --><ul><li>If practical, have someone other than the patient administer the treatment.</li><li>If there is substantial exudate, remove this by gentle (atraumatic) dry swabbing using a cotton bud or twist of cotton wool.</li><li>Warm the drops up to body temperature by holding the bottle in hands or pocket for a few minutes — this prevents the dizziness that can occur if cold drops are administered.</li><li>To administer the ear drops to ensure optimal delivery throughout the external ear canal:<ul><li>The person should lie down with the ear to be treated uppermost.</li><li>The ear canal should be filled with ear drops. Gently pulling and pushing the ear helps to let air out of, and liquid into, the ear canal.</li><li>The person should remain in this position for 3–5 minutes. A kitchen timer may be useful to get young children to cooperate.</li><li>If the person (for example a small child) cannot lie still long enough to allow absorption, a small cotton plug covered with petroleum jelly or moistened with the drops and placed at the external opening of the ear canal for about 5 minutes can be used to help retain the drops in the ear.</li><li>A small cotton swab placed at the tragus can be used to catch any leakage from the ear when sitting up.</li><li>The ear canal should be left open to dry.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">Rosenfeld, 2014</a>]</p><!-- end field 800f79f3-6364-4867-92ba-3a4c9648691f --><!-- end item c1c3d488-24f8-4576-9fa5-2e6f123c81cc -->","subChapters":[]},{"id":"a53903ee-2d82-5bd3-a798-93ebb82f8051","slug":"contraindications","fullItemName":"Contraindications","depth":3,"htmlHeader":"<!-- begin field a115445a-c685-43fd-b319-31a28e03f863 --><h3>What are the contraindications for topical ear preparations?</h3><!-- end field a115445a-c685-43fd-b319-31a28e03f863 -->","summary":"","htmlStringContent":"<!-- begin item d027fbb8-9580-4442-93b9-e48890c7c4c1 --><!-- begin field 1aeb3016-94d9-4489-a6ac-efe2ba5d9469 --><ul><li>Ototoxicity with aminoglycoside antibiotics:<ul><li>Topical aminoglycosides are contraindicated in people with a perforated tympanic membrane.</li></ul></li><li>People with (or a history of) a local sensitivity reaction should avoid preparations with the same class of drug associated with the reaction. For example, if neomycin is thought to have caused a sensitivity reaction all preparations containing aminoglycosides should be avoided.</li><li>Sensitivity reactions:<ul><li>Prolonged or recurrent use of topical preparations can result in sensitization of the auricle or external auditory canal, leading to an allergic reaction (secondary contact otitis).</li><li>This reaction can be caused by the drug itself or excipients found in the vehicle (see Table 2).</li><li>The aminoglycoside, neomycin, is the most common substance in topical ear preparations causing sensitization.<ul><li>Neomycin has been reported to cause reactions in about 5–15% of patients with chronic external otitis.</li><li>There are significant cross-reactions with framycetin and gentamicin.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">Rosenfeld, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">Sood et al, 2002</a>]</p><p><strong>Table 2</strong><strong>. </strong>Compounds in topical ear preparations reported to cause sensitization.</p><table><thead><tr><th colspan=\"1\"><p>Group</p></th><th colspan=\"1\"><p>Chemicals</p></th></tr></thead><tbody><tr><td colspan=\"1\">Antibiotics</td><td colspan=\"1\">Neomycin, Gentamicin sulphate 1%, Framycetin, Polymyxin B sulphate, Chloramphenicol, Bacitracin</td></tr><tr><td colspan=\"1\">Corticosteroids</td><td colspan=\"1\">Hydrocortisone</td></tr><tr><td colspan=\"1\">Excipients</td><td colspan=\"1\">Benzethonium chloride (preservative), Benzalkonium chloride 0.1% (preservative), Caine mix, Methyl-methacrylate, Methyl-p-oxybenzoate (preservative), Methylrosaniline (Gentian violet), Nickel sulphate 5%, Propylene glycol (preservative), Quinolone mix 6%, Thimerosal merthiolate (preservative)</td></tr><tr><td colspan=\"2\"><strong>Data from:</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/otitis-externa/references/\">Sood et al, 2002</a>]</td></tr></tbody></table><!-- end field 1aeb3016-94d9-4489-a6ac-efe2ba5d9469 --><!-- end item d027fbb8-9580-4442-93b9-e48890c7c4c1 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}